Lynwood's health economy runs on connected equipment - and the sharpest risk is the medical device nobody can patch, sitting on the same VLAN as everything else. CyberFortify runs manual IoMT/device, network segmentation, API and cloud penetration tests here, aligned to FDA device cybersecurity guidance, IEC 80001, the HIPAA Security Rule and NIST CSF. Testing never touches a device attached to a patient. Delivered remotely from our Gulf base on a daily overlap window, with on-site work where a tester must be on the clinical wire. Fixed price, audit-ready reporting, free retest.
// 01 Why Lynwood businesses need penetration testing
Walk a hospital floor in Lynwood and count the things with an IP address: infusion pumps, bedside monitors, ventilators, ultrasound carts, the CT and MR that feed the imaging archive. Most were bought as clinical equipment, not as computers, and most were never scoped to defend themselves. They run whatever operating system shipped with them - often one that reached end of support years ago and cannot be patched without re-validating the whole device.
The failure mode is the flat network. Where the clinical VLAN is not truly segmented, a monitor in one ward and the imaging archive in another can reach each other, and anything that lands on that segment - a phishing foothold on a nursing workstation, a compromised vendor laptop - can reach a device that has no meaningful authentication. That is how one legacy box becomes the pivot into a patient-care environment, and why ransomware in healthcare so often spreads through the devices rather than around them.
A vulnerability scanner will not tell you this. It flags the unpatched OS and stops. It cannot tell you that the infusion pump accepts management commands from any host on its subnet, that the PACS answers a DICOM association without asking who is calling, or that the "segmented" biomedical VLAN is one misconfigured firewall rule away from the corporate network. Confirming those takes a tester who understands the protocols, the devices and the clinical constraints around touching them.
// 02 Compliance and regulatory drivers in Lynwood
Medical-device security in a Lynwood provider answers to device-specific FDA expectations, a network-risk standard written for exactly this problem, and the federal privacy regime over the data those devices produce. These are the requirements we most often map evidence against.
FDA premarket cyber-device guidance
Under Section 524B, the FDA can refuse to accept a device submission that lacks a cybersecurity plan and evidence. Hospitals increasingly ask vendors to prove it, and independent testing is how that evidence is produced.
FDA postmarket device guidance
Fielded devices carry ongoing risk-management duties. We test how a deployed device behaves on your actual network, not the vendor's lab, and document what a real attacker on the VLAN can reach.
IEC 80001
The standard for risk management when medical devices are placed on IT networks. It frames the segmentation problem directly, and our findings feed the risk file your clinical engineering team maintains.
HIPAA Security Rule - risk analysis & evaluation
Covered entities must run an accurate risk analysis and periodically re-evaluate technical safeguards. A connected device holding or transmitting ePHI is in scope, and independent testing is how most Lynwood providers evidence it.
HITECH breach notification
HITECH sets the notification duties that follow an unauthorised disclosure. A device that exposes patient data or a study on the imaging archive is a potential notification event, so we prioritise findings by patient-safety and disclosure impact.
NIST CSF & PCI DSS v4.0
Many providers anchor the security programme to NIST CSF, and any patient-payment or billing environment must penetration-test and prove segmentation of the cardholder scope under Req 11.4.
// 03 Penetration testing services for Lynwood
Lynwood engagements lead with the devices and the network they live on, because that is where patient-safety risk concentrates. Device and IoMT testing comes first; network segmentation testing proves the containment around it; API and cloud cover the systems that ingest and store what the devices produce.
IoMT & device pen testing
Infusion pumps, monitors, imaging and biomedical devices - default and hardcoded credentials, exposed management interfaces, firmware and DICOM/PACS exposure, proven on bench or decommissioned units.
Network & segmentation testing
Does the clinical VLAN actually contain the devices? External, internal and Active Directory testing plus explicit segmentation checks between biomed, clinical and corporate zones.
Building & facility systems
Nurse-call, building management, physical-access and other OT that shares hospital infrastructure and often the same weak isolation as the medical devices.
API pen testing
The interfaces that carry device telemetry and imaging into the EHR and archive - broken object-level authorisation, scope enforcement and token handling.
Cloud pen testing
Identity, tenant isolation and storage exposure across the platforms hosting imaging archives, device-management consoles and clinical data.
Red teaming
Goal-based adversary simulation, including ransomware scenarios that pivot through unmanaged devices, testing whether the intrusion is detected before care is disrupted.
// 04 How we deliver to Lynwood
We will not pretend otherwise: CyberFortify is a Gulf-based firm on UTC+3, and Lynwood sits ten to eleven hours behind us. We have no California office and no local staff. What we have is a working pattern built around that gap: our late afternoon and evening is your morning, and we hold that window open daily for stand-ups, live triage and read-outs. That coordination matters more here than usual, because clinical maintenance windows have to be agreed with biomed and clinical engineering before anything is touched. Testing continues while Lynwood is offline, so confirmed results are waiting when your day starts.
What runs remotely
API, cloud, external testing and passive device and network discovery from our secure environment. We map the clinical attack surface and confirm what can reach what, escalating anything that touches device availability rather than pushing it.
What we do on-site
Internal, wireless and segmentation testing on the clinical wire, plus hands-on work with bench or decommissioned devices alongside your biomedical team. We travel when the test genuinely needs a tester on-premises and say so when it does not.
Every engagement opens with a free 30-minute scoping call and a fixed-price quote within the hour. We agree test windows and abort conditions around patient care first, never after, and a free retest proves the fixes and the segmentation changes.
// 05 Industries we secure in Lynwood
Lynwood's risk profile is shaped by a dense concentration of healthcare delivery around a major medical centre, with the connected devices and clinical networks that come with it.
// 06 Our methodology
Lynwood engagements follow the same audit-defensible process we run everywhere, tuned to the patient-safety constraints of a live clinical environment. Testing is grounded in the PTES and NIST SP 800-115, with exploitation mapped to MITRE ATT&CK tactics and device work informed by the FDA and IEC 80001 risk framing. As a CREST Accreditation Pathway firm we lead with manual testing - automation supports the tester, and never runs unattended against a medical device.
Scoping & rules of engagement
Device classes, VLANs, bench and decommissioned units, maintenance windows and explicit abort conditions agreed in writing with biomed first.
Fixed quote in 1hDiscovery & threat modelling
Passive device and network discovery maps the clinical attack surface - what is on each VLAN, what it trusts, and what a foothold on the segment can reach.
ATT&CK alignedSafe exploitation
Weaknesses are proven on bench or decommissioned units and through segmentation testing - never on a device attached to a patient - with availability-affecting actions escalated, not executed live.
Patient-safeReporting & free retest
Executive summary, CVSS-scored detail and mapping to FDA guidance, IEC 80001, HIPAA and NIST CSF - plus a free retest once fixes and segmentation ship.
Audit-ready// 07 Why CyberFortify for Lynwood
A scan-and-report vendor
Automated output rebadged as a penetration test, flagging an unpatched device OS and stopping - blind to whether the device authenticates, what its VLAN really contains, or whether a scan alone could knock it offline mid-shift.
CyberFortify
A Gulf-based, CREST-pathway team candid about the time difference and structured around your clinical windows. Manual testing aimed at the device and the segmentation around it, proven on safe targets, mapped to the FDA, IEC 80001 and HIPAA evidence your assessors and vendors cite - fixed pricing and a free retest.
Lynwood engagements most often pair an IoMT/device assessment with network segmentation testing, because a device's real risk is the sum of its own weakness and what the network lets that weakness reach. Where downtime is a patient-safety event, we add red teaming to test whether a ransomware pivot through unmanaged devices is detected before care is disrupted.
// 08 Frequently asked questions
Do you test connected medical devices without endangering patients in Lynwood?
Patient safety governs the whole engagement. We never test a device that is attached to a patient or in active clinical use. Instead we work bench units, decommissioned or spare equipment, and agreed maintenance windows, with clear abort conditions written into the rules of engagement before any packet is sent. On the live network we favour passive discovery and traffic analysis, and we escalate anything that could affect availability rather than pushing it. The aim is to prove the exposure exists using a safe target, not to prove it on a device keeping someone alive.
How do you test infusion pumps, patient monitors and PACS/DICOM imaging?
We treat each class on its own terms. For infusion pumps and monitors we look for default or hardcoded credentials, unauthenticated management interfaces, firmware and configuration exposure, and whether a device trusts commands from anywhere on its VLAN. For imaging we test the DICOM and PACS layer directly: whether the service accepts association requests without authentication, whether studies can be queried, retrieved or altered by an unauthorised host, and whether the archive is reachable from general clinical or corporate subnets. Findings are proven on bench or decommissioned units and mapped to the device's own risk profile.
Which regulations and standards drive medical-device testing for Lynwood providers?
FDA premarket and postmarket cybersecurity guidance sets the expectations for device makers, and the Section 524B cyber-device requirements give the FDA grounds to refuse to accept a submission that lacks a security plan - so hospitals increasingly ask their vendors to evidence it. IEC 80001 governs risk management when medical devices are placed on IT networks, which is exactly the segmentation problem most providers face. On top of that, the HIPAA Security Rule requires risk analysis and periodic technical evaluation, HITECH governs breach notification, and many programmes anchor to NIST CSF. We map every finding to the standard your assessors and your device vendors will cite.
With your team in the Gulf, how does the time gap work for a Lynwood engagement?
We will be plain: CyberFortify is a Gulf-based firm on UTC+3, ten to eleven hours ahead of Lynwood, with no California office and no local staff. We hold a deliberate daily overlap window open - our late afternoon and evening is your morning - for stand-ups, live triage and read-outs, which matters more than usual here because clinical maintenance windows have to be agreed with biomed and clinical engineering. Testing continues while your team is offline, so confirmed findings are usually waiting when the day starts.
How fast can we get a quote for a Lynwood engagement?
Book a free 30-minute scoping call and we return a fixed-price quote, usually within the hour and always within one business day. The report is written to hand straight to an auditor or a device vendor, and a remediation retest is included once your fixes and segmentation changes ship.